Introduction
Preterm prelabor rupture of membranes (pPROM) complicates 2.5 ~ 3% of pregnancies and is responsible for one third of preterm birth [
1,
2]. The practice bulletins released by the American Congress of Obstetricians and Gynecologists (ACOG) and the Royal College of Obstetricians and Gynaecologists (RCOG) endorses antibiotics, corticosteroid, induction or expectant management [
1,
3].
Perinatal complications are common burdens for infants born from mother with pPROM. The consequences of pPROM for neonates are premature birth complications [
4], short-term neonatal disease(neonatal pneumonia, neonatal sepsis, et al.) [
5] and long-term disability (blindness, deafness and cerebral palsy) [
6]. It is reported that the risk of neurodevelopmental impairment for neonates would be higher if the mother who suffer from preterm PROM with intrauterine inflammation [
7,
8], and the risk of neonatal white matter damage would be associated with early gestational age at membrane rupture [
9]. The most common reported complication of prematurity is respirator [
4]. Necrotizing enterocolitis (NEC) and intraventricular hemorrhage (IVH), and sepsis are also reported to be associated with preterm birth.
Perinatal mortality and the incidence of severe neonatal morbidity are higher in those preterm infants with lower birthweight [
4,
10,
11]. There were several studies developed graphical tools or model to predict survival or survival without severe morbidities in preterm infants [
12‐
14]. To facilitate prediction in PROM pregnancies, Jose R. Ducan et al. used clinical variables obtainable before delivery for severe neonatal outcomes and found estimated fetal weight showed significant effect on the prediction probability of the SNO [
15]. Physicians and parents sometimes need to make critical decisions about neonatal care with short- and long-term implications on infant’s health and families. As postnatal clinical data could be available to neonatologists, here we conducted a study to find the association of clinical variables obtained before or after delivery for severe neonatal outcomes (SNO) and develop a valid but simple clinical tool using these variables to assess the risk of these outcomes.
Materials and methods
This was a further study of the previous cohort (MCPPNC, Multi-center Cohort of Pregnancies with PROM and their Neonates in China), a prospective, multi-center cohort study aimed to describe the epidemiology of PROM and assess the influence of the implementation of the guideline [
2].
As described in our previously published study [
2], PROM was defined as rupture of membranes before the on-set of labor [
1]. PROM was confirmed by pooling and positive PROM test (PH test or insulin-like growth factor binding protein 1 detection test). Briefly, PROM pregnancies were recruited between August 1, 2017, to March 31, 2018 from three hospitals (Shenzhen Baoan Maternity and Children’s Hospital, Xibei Women and Children’s Hospital and Chengdu Women and Children’s Hospital) in China. Participants whose estimated gestational age (GA) of ≥ 42 weeks and < 24 weeks were excluded. Demographic and clinical data were collected. This study was approved by the Ethical Committee of PLA Army General Hospital, China (2017–42) and assigned on the Protocol Registration and Results System of ClinicalTrials.gov (NCT03251898).
In the present study, we included pregnancies with PROM at preterm (estimated GA < 37 weeks from MCPPNC) with a single fetus. The outcome of neonates who were hospitalized in neonatology department were followed until they were leave hospital.
Severe neonatal outcomes (SNO) were defined as the following: necrotizing enterocolitis (NEC), respiratory distress syndrome (RDS), intraventricular hemorrhage (IVH), neonatal sepsis, bronchopulmonary dysplasia (BPD) and neonatal death. RDS was defined as surfactant deficiency based on clinical or radiologic evidences [
16]. According to Bell’s staging, stage II and III was defined as NEC [
17], IVH was defined according to the Papille classification [
18]. Sepsis was defined by the presence of clinical symptoms and a positive culture from blood or cerebrospinal fluid samples. BPD was diagnosed according to NIH 2018 definition [
19].
As defined in our previous published study, clinical chorioamnionitis was characterized by maternal fever, leukocytosis, maternal and/or foetal tachycardia and uterine tenderness [
2,
20]. Subclinical/histologic chorioamnionitis which is asymptomatic, was confirmed by pathological section of placenta. We defined degree I, II and III meconium-stained amniotic fluid as “amniotic fluid pollution” [
2,
21,
22]. Gestational hypertensive (GH) is defined as a systolic blood pressure of 140 mm Hg or more or a diastolic blood pressure of 90 mm Hg or more, or both, on two occasions at least 4 h apart after 20 weeks of gestation in a woman with a previously normal blood pressure [
2,
23]; The definition of diabetes mellitus arising in pregnancy (DMP) were according to the international classification of Diseases (ICD), 11
th Revision (
https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1320503631) [
2];
Statistical analyses
Statistical analysis was carried out with the R software (Version 4.1.2;
https://www.R-project.org). rms (version 6.0–1) [
24] for logistic regression modelling, pROC (version 1.16.2) [
25] for C-statistic calculations, rmda (version 1.6) [
26] for decision curve analysis.
Multivariable logistic regression analysis was performed to establish a predicting model. The clinical variables included in the regression model were “Respiratory support on the first day: Oxygen therapy (oxygen inhalation in incubator, oxygen inhalation with facemask, oxygen inhalation in oxygen chamber), Normal frequency ventilation (including the use of continuous positive airway pressure (CPAP) and synchronized intermittent mandatory ventilation (SIMV)), and High-frequency ventilation (HFO), the use of surfactant on the first day, clinical or subclinical chorioamnionitis, DMP, GH, birthweight, the use of antenatal corticosteroids, latency days from PROM to delivery, and amniotic fluid pollution”. The variables were selected by stepwise selection. The statistical significance levels were all two sided. All suspected predictors were incorperated to develop a prediction model for SNO risk by using the cohort.
The SNO nomogram was assessed by calibration curves. The model would not be considered to calibrate perfectly if there was a significant test statistic. The discrimination performance of the SNO nomogram was quantified by the Harrell’s C-index. The nonadherence nomogram was subjected to enhanced bootstrapping validation (1,000 bootstrap resamples) to calculate a relatively corrected C-index [
27]. The clinical usefulness of the nomogram was determined by conducting decision curve analysis [
28] and by quantifying the net benefits at different threshold probabilities for model development by simple predictor birth weight and complex predictors selected by stepwise method.
Discussion
We developed and validated a prognostic model for SNO among 1101 preterm neonates hospitalized in department of neonatology. The final model integrated three routinely available predictors and could be used at the point of admission for preterm neonates. Internal validation showed consistent discrimination and calibration in the cohort for development of the model. Our model provides a probability output that could indicate the chance of the individual under evaluation having the outcome. These predictions would enable clinicians to objectively assess deterioration risk to inform the need for interventions such as ongoing hospital admission, consideration for critical care, and initiation of therapeutic agents.
In the development of our model, factors that were supposed to affect neonatal outcomes were included. “Respiratory support on the first day, the use of surfactant on the first day and birthweight” were suggested to be the key individual factors that determine risk of SNO. These factors in our final model are also well-known predictors of survival in preterm infants [
29,
30]. As expected, birthweight was the strongest predictor. Neonates who were received CPAP or SIMV were at risk (adjusted OR = 4.040, 95%CI [2.345, 6.958],
p < 0.001) than those who did not need respiratory support. Those who received HFO were at high risk (adjusted OR = 8.781, 95%CI [1.803, 42.770],
p = 0.007) of SNO. Neonates received surfactant on Day 1 showed great risk of SNO (adjusted OR = 21.221, 95%CI [4.661, 96.622],
p < 0.001).
A recent study for prediction of SNO conducted by Jose R. Duncan et al. [
15] reported that estimated fetal weight could be used as a clinical toll to calculate the prediction probability of SNO in PPROM. In their model, several variables available before delivery such as gestational age, diabetes mellitus, fetal growth restriction and the appearance of clinical chorioamnionitis et al. were enrolled in their model. However, only estimated fetal weight were left as the predictor. The findings in our study echoed the study that factors obtained before delivery including clinical or subclinical chorioamnionitis, DMP, GH, the use of antenatal corticosteroids, latency days from PROM to delivery and amniotic fluid pollution were all adjusted.
Another study in Canada [
14] recruited over 6000 preterm infants born from 23 to 30 weeks of gestation to develop accurate predictors models for multiple severe perinatal outcomes. 8 predictors, including gestational age, small for gestational age, gender, inborn or outborn status, antenatal corticosteroid use, SNAPII score > 20, and receipt of surfactant and mechanical ventilation on the first day after NICU admission were enrolled. Although prenatal and postnatal indicators, such as first trimester ultrasound, last menstrual period (LMP) and neonatal data were used to determine gestational age for individual infant management in nowadays [
31], the gestational age before birth in medical record was still mainly the one that estimated based on maternal recollection of the last normal menstrual period (LNMP) that would be fraught with error. Thus, we used birth weight instead of gestational age in our model.
Esteves JS et al. conducted a study included 61 pregnancies with PPROM from 18 to 26 weeks of gestation from Brazil. The investigators demonstrated the only predictor for survival was the birthweight with an AUC of 0.90 [
32]. While our model which included “Respiratory support on the first day, the use of surfactant on the first day and birthweight” as predictors achieved higher net benefit than model with birthweight as the only one predictor if the threshold is > 15%. The clinical effect curve of the complex model also showed better result than that of the simple model.
The limitation of our study was that considering that model using a smaller training subset may exclude important risk factors that do not reach the required statistical significance threshold because of reduced power, we included all the data from 3 centers into our model for developing the prognostic nomogram. Therefore, we recommend that our model be validated in larger and more diverse populations. Second, there were lack of a more precise level of IVH.
Conclusions
In conclusion, the birthweight, respiratory support on the first day, the receipt of surfactant, had association for SNO in neonates born from mother with PPROM. We presented a prediction nomogram that appears to accurately estimate the probability for severe neonatal outcomes in pregnancies complicated by PPROM. The prognostic nomogram need validation in more diverse and larger populations.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.